Would you disagree that at the early customer adoption of 30% growth month on month without much digital platform, is not going to grow to 30-50% early growth over at least the first 2-3 quarters?
Then extrapolate what those numbers are, and calculate the sales figures, which I have done. It's not chest-beating. It's just cutting through the emotion, fear, and crap posted by some that are panicking because of the short-term share price depreciation.
Crystal clear- Its completely normal for a good company to retrace 40-45% in share price without anything being wrong.
If I was going to chest-beat, I would say,
'How many bleeting times do I have to highlight the 4 major things that have unsettled markets over the past 3 months, particularly impacting risk management strategies of funds to reduce risk in their Healthcare and Bio stock positions? And how many times do I have to bleet out that if earnings per share is increasing exponentially, that the price will revert back to being strong. Beyond that, everything is out of our control which is why we have STOP LOSSES if the losses are too great for our emotional & financial capacity to handle"
BOT Price at posting:
29.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)